Purification and characterization of botulinum neurotoxin FA from a genetically modified Clostridium botulinum strain

mSphere

Volumn 1, Issue 1, 2016, Pages

  Pellett, Sabine ^a   Tepp, William H ^a   Bradshaw, Marite ^a   Kal, Suzanne R ^b,c   Dykes, Janet K ^b   Lin, Guangyun ^a   Nawrocki, Erin M ^a   Pier, Christina L ^a   Barr, John R ^c   Maslank, Susan E ^a,b   Johnson, Eric A ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^c NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

Author keywords

BoNT FA; Botulinum neurotoxin; Chimeric toxin; Clostridium botulinum

Indexed keywords

EID: 85010348253     PISSN: None     EISSN: 23795042     Source Type: Journal    
DOI: 10.1128/mSphere.00100-15     Document Type: Article

References (57)

1. Rossetto O, Pirazzini M, Montecucco C. 2014. Botulinum neurotoxins: genetic, structural and mechanistic insights. Nat Rev Microbiol 12: 535-549. http://dx.doi.org/10.1038/nrmicro3295
2. Johnson EA, Montecucco C. 2008. Chapter 11. Botulism, p 333-368. In Engel AWG (ed), Handbook of clinical neurology, vol 91. Neuromuscular junction disorders. Elsevier, Amsterdam, The Netherlands
3. Centers for Disease Control and Prevention. 2010. Investigational heptavalent botulinum antitoxin (HBAT) to replace licensed botulinum antitoxin AB and investigational botulinum antitoxin E. MMWR Morb Mortal Wkly Rep 59:299
4. Arnon SS. 1980. Infant botulism. Annu Rev Med 31:541-560. http:// dx.doi.org/10.1146/annurev.me.31.020180.002545
5. Arnon SS, Schechter R, Maslanka SE, Jewell NP, Hatheway CL. 2006. Human botulism immune globulin for the treatment of infant botulism. N Engl J Med 354:462-471. http://dx.doi.org/10.1056/NEJMoa051926
6. Arnon SS, Schechter R, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Fine AD, Hauer J, Layton M, Lillibridge S, Osterholm MT, O'Toole T, Parker G, Perl TM, Russell PK, Swerdlow DL, Tonat K, Working Group on Civilian Biodefense. 2001. Botulinum toxin as a biological weapon: medical and public health management. JAMA 285:1059-1070
7. Balali-Mood M, Moshiri M, Etemad L. 2013. Medical aspects of bioterrorism. Toxicon 69:131-142. http://dx.doi.org/10.1016/ j.toxicon.2013.01.005
8. Peck MW, Stringer SC, Carter AT. 2011. Clostridium botulinum in the post-genomic era. Food Microbiol 28:183-191. http://dx.doi.org/ 10.1016/j.fm.2010.03.005
9. Hill KK, Smith TJ, Helma CH, Ticknor LO, Foley BT, Svensson RT, Brown JL, Johnson EA, Smith LA, Okinaka RT, Jackson PJ, Marks JD. 2007. Genetic diversity among botulinum neurotoxin-producing clostridial strains. J Bacteriol 189:818-832. http://dx.doi.org/10.1128/ JB.01180-06
10. Gimenez DF, Gimenez JA. 1992. Serological subtypes of botulinum neurotoxins, p 421-431. In DasGupta BR (ed), Botulinum and tetanus neurotoxins: neurotransmission and biomedical aspects. Plenum Press, New York, NY
11. Hatheway CL, Johnson EA. 1998. Clostridium: the spore bearing anaerobes, p 731-782. In Collier L, Ballows A, Sussman M (ed), Topley and Wilson's microbiology and microbial infections, vol 2, 9th ed. Arnold, London, United Kingdom
12. Hill KK, Smith TJ. 2013. Genetic diversity within Clostridium botulinum serotypes, botulinum neurotoxin gene clusters and toxin subtypes. Curr Top Microbiol Immunol 364:1-20. http://dx.doi.org/10.1007/978-3-642-33570-9_1
13. Montecucco C, Rasotto MB. 2015. On botulinum neurotoxin variability. mBio 6:e02131-14. http://dx.doi.org/10.1128/mBio.02131-14
14. Hatheway CL, McCroskey LM, Lombard GL, Dowell VR, Jr. 1981. Atypical toxin variant of Clostridium botulinum type B associated with infant botulism. J Clin Microbiol 14:607-611
15. Giménez DF. 1984. Clostridium botulinum subtype Ba. Zentralbl Bakteriol Mikrobiol Hyg A 257:68-72
16. Giménez DF, Giménez JA. 1983. Identification of strain B 657 of Clostridium botulinum. Rev Argent Microbiol 15:51-55
17. Ciccarelli AS, Gimenez DF. 1971. Serological study of Clostridium botulinum type A and strain 84 toxins. Rev Latinoam Microbiol 13:67-74
18. Franciosa G, Ferreira JL, Hatheway CL. 1994. Detection of type A, B, and E botulism neurotoxin genes in Clostridium botulinum and other Clostridium species by PCR: evidence of unexpressed type B toxin genes in type A toxigenic organisms. J Clin Microbiol 32:1911-1917
19. Hutson RA, Zhou Y, Collins MD, Johnson EA, Hatheway CL, Sugiyama H. 1996. Genetic characterization of Clostridium botulinum type A containing silent type B neurotoxin gene sequences. J Biol Chem 271:10786-10792. http://dx.doi.org/10.1074/jbc.271.18.10786
20. Kalb SR, Baudys J, Smith TJ, Smith LA, Barr JR. 2014. Three enzymatically active neurotoxins of Clostridium botulinum strain Af84: BoNT/A2, /F4, and /F5. Anal Chem 86:3254-3262. http://dx.doi.org/10.1021/ ac5001509
21. Barash JR, Arnon SS. 2004. Dual toxin-producing strain of Clostridium botulinum type Bf isolated from a California patient with infant botulism. J Clin Microbiol 42:1713-1715. http://dx.doi.org/10.1128/JCM.42.4.1713-1715.2004
22. Barash JR, Arnon SS. 2014. A novel strain of Clostridium botulinum that produces type B and type H botulinum toxins. J Infect Dis 209:183-191. http://dx.doi.org/10.1093/infdis/jit449
23. Dover N, Barash JR, Hill KK, Xie G, Arnon SS. 2014. Molecular characterization of a novel botulinum neurotoxin type H gene. J Infect Dis 209:192-202. http://dx.doi.org/10.1093/infdis/jit450
24. Kalb SR, Baudys J, Raphael BH, Dykes JK, Lúquez C, Maslanka SE, Barr JR. 2015. Functional characterization of botulinum neurotoxin serotype H as a hybrid of known serotypes F and A (BoNT F/A). Anal Chem 87:3911-3917. http://dx.doi.org/10.1021/ac504716v
25. Gonzalez-Escalona N, Thirunavukkarasu N, Singh A, Toro M, Brown EW, Zink D, Rummel A, Sharma SK. 2014. Draft genome sequence of bivalent Clostridium botulinum strain IBCA10-7060, encoding botulinum neurotoxin B and a new FA mosaic type. Genome Announc 2(6):e01275-14. http://dx.doi.org/10.1128/genomeA.01275-14
26. Maslanka SE, Lúquez C, Dykes JK, Tepp WH, Pier CL, Pellett S, Raphael BH, Kalb SR, Barr JR, Rao A, Johnson EA. 2016. A novel botulinum neurotoxin, previously reported as serotype H, has a hybridlike structure with regions of similarity to the structures of serotypes A and F and is neutralized with serotype A antitoxin. J Infect Dis 213: 379-385. http://dx.doi.org/10.1093/infdis/jiv327
27. Nakamura K, Kohda T, Seto Y, Mukamoto M, Kozaki S. 2013. Improved detection methods by genetic and immunological techniques for botulinum C/D and D/C mosaic neurotoxins. Vet Microbiol 162: 881-890. http://dx.doi.org/10.1016/j.vetmic.2012.11.009
28. Moriishi K, Koura M, Abe N, Fujii N, Fujinaga Y, Inoue K, Ogumad K. 1996. Mosaic structures of neurotoxins produced from Clostridium botulinum types C and D organisms. Biochim Biophys Acta 1307:123-126. http://dx.doi.org/10.1016/0167-4781(96)00006-1
29. Pier CL, Tepp WH, Bradshaw M, Johnson EA, Barbieri JT, Baldwin MR. 2008. Recombinant holotoxoid vaccine against botulism. Infect Immun 76:437-442. http://dx.doi.org/10.1128/IAI.00843-07
30. Bradshaw M, Tepp WH, Whitemarsh RC, Pellett S, Johnson EA. 2014. Holotoxin activity of botulinum neurotoxin subtype A4 originating from a nontoxigenic Clostridium botulinum expression system. Appl Environ Microbiol 80:7415-7422. http://dx.doi.org/10.1128/AEM.01795-14
31. Moreira GM, Cunha CE, Salvarani FM, Gonçalves LA, Pires PS, Conceição FR, Lobato FC. 2014. Production of recombinant botulism antigens: a review of expression systems. Anaerobe 28:130-136. http:// dx.doi.org/10.1016/j.anaerobe.2014.06.003
32. Bradshaw M, Marshall KM, Heap JT, Tepp WH, Minton NP, Johnson EA. 2010. Construction of a nontoxigenic Clostridium botulinum strain for food challenge studies. Appl Environ Microbiol 76:387-393. http:// dx.doi.org/10.1128/AEM.02005-09
33. Marshall KM, Bradshaw M, Johnson EA. 2010. Conjugative botulinum neurotoxin-encoding plasmids in Clostridium botulinum. PLoS One 5:e11087. http://dx.doi.org/10.1371/journal.pone.0011087
34. Heap JT, Kuehne SA, Ehsaan M, Cartman ST, Cooksley CM, Scott JC, Minton NP. 2010. The ClosTron: mutagenesis in Clostridium refined and streamlined. J Microbiol Methods 80:49-55. http://dx.doi.org/10.1016/ j.mimet.2009.10.018
35. Heap JT, Pennington OJ, Cartman ST, Carter GP, Minton NP. 2007. The ClosTron: a universal gene knockout system for the genus Clostridium. J Microbiol Methods 70:452-464. http://dx.doi.org/10.1016/ j.mimet.2007.05.021
36. Knox JN, Brown WP, Spero L. 1970. The role of sulfhydryl groups in the activity of type A botulinum toxin. Biochim Biophys Acta 214:350-354. http://dx.doi.org/10.1016/0005-2795(70)90012-7
37. Yamasaki S, Baumeister A, Binz T, Blasi J, Link E, Cornille F, Roques B, Fykse EM, Südhof TC, Jahn R. 1994. Cleavage of members of the synaptobrevin/VAMP family by types D and F botulinal neurotoxins and tetanus toxin. J Biol Chem 269:12764-12772
38. Whitemarsh RC, Strathman MJ, Chase LG, Stankewicz C, Tepp WH, Johnson EA, Pellett S. 2012. Novel application of human neurons derived from induced pluripotent stem cells for highly sensitive botulinum neurotoxin detection. Toxicol Sci 126:426-435. http://dx.doi.org/ 10.1093/toxsci/kfr354
39. Giménez DF, Ciccarelli AS. 1978. New strains of Clostridium botulinum subtype Af. Zentralbl Bakteriol Orig A 240:215-220
40. Franciosa G, Hatheway CL, Aureli P. 1998. The detection of a deletion in the type B neurotoxin gene of Clostridium botulinum A(B) strains by a two-step PCR. Lett Appl Microbiol 26:442-446. http://dx.doi.org/ 10.1046/j.1472-765X.1998.00367.x
41. Kirma N, Ferreira JL, Baumstark BR. 2004. Characterization of six type A strains of Clostridium botulinum that contain type B toxin gene sequences. FEMS Microbiol Lett 231:159-164. http://dx.doi.org/10.1016/ S0378-1097(03)00911-X
42. Dover N, Barash JR, Hill KK, Davenport KW, Teshima H, Xie G, Arnon SS. 2013. Clostridium botulinum strain Af84 contains three neurotoxin gene clusters: bont/A2, bont/F4 and bont/F5. PLoS One 8:e61205. http:// dx.doi.org/10.1371/journal.pone.0061205
43. Giménez DF, Ciccarelli AS. 1970. Studies on strain 84 of Clostridium botulinum. Zentralbl Bakteriol Orig 215:212-220
44. Smith GE, Hinde F, Westmoreland D, Berry PR, Gilbert RJ. 1989. Infantile botulism. Arch Dis Child 64:871-872. http://dx.doi.org/10.1136/ adc.64.6.871
45. Lin G, Tepp WH, Bradshaw M, Fredrick CM, Johnson EA. 2015. Immunoprecipitation of native botulinum neurotoxin complexes from Clostridium botulinum subtype A strains. Appl Environ Microbiol 81: 481-491. http://dx.doi.org/10.1128/AEM.02817-14
46. Kalb SR, Baudys J, Webb RP, Wright P, Smith TJ, Smith LA, Fernández R, Raphael BH, Maslanka SE, Pirkle JL, Barr JR. 2012. Discovery of a novel enzymatic cleavage site for botulinum neurotoxin F5. FEBS Lett 586:109-115. http://dx.doi.org/10.1016/j.febslet.2011.11.033
47. Kalb SR, Lou J, Garcia-Rodriguez C, Geren IN, Smith TJ, Moura H, Marks JD, Smith LA, Pirkle JL, Barr JR. 2009. Extraction and inhibition of enzymatic activity of botulinum neurotoxins/A1, /A2, and /A3 by a panel of monoclonal anti-BoNT/A antibodies. PLoS One 4:e5355. http:// dx.doi.org/10.1371/journal.pone.0005355
48. Smith TJ, Lou J, Geren IN, Forsyth CM, Tsai R, Laporte SL, Tepp WH, Bradshaw M, Johnson EA, Smith LA, Marks JD. 2005. Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization. Infect Immun 73:5450-5457. http://dx.doi.org/ 10.1128/IAI.73.9.5450-5457.2005
49. Goodnough MC, Hammer B, Sugiyama H, Johnson EA. 1993. Colony immunoblot assay of botulinal toxin. Appl Environ Microbiol 59: 2339-2342
50. Sambrook J, MacCallum P, Russell D. 2001. Molecular cloning: a laboratory manual, 3rd ed. CSHL Press, New York, NY
51. Hall YH, Chaddock JA, Moulsdale HJ, Kirby ER, Alexander FC, Marks JD, Foster KA. 2004. Novel application of an in vitro technique to the detection and quantification of botulinum neurotoxin antibodies. J Immunol Methods 288:55-60. http://dx.doi.org/10.1016/j.jim.2004.02.011
52. Pellett S, Tepp WH, Clancy CM, Borodic GE, Johnson EA. 2007. A neuronal cell-based botulinum neurotoxin assay for highly sensitive and specific detection of neutralizing serum antibodies. FEBS Lett 581: 4803-4808. http://dx.doi.org/10.1016/j.febslet.2007.08.078
53. Schantz EJ, Kauter DA. 1978. Standardized assay for Clostridium botulinum toxins. J Assoc Off Anal Chem 61:96-99
54. Hatheway CL. 1988. Botulism, p 111-133. In Balows A, Hausler WH, Ohashi M, Turano MA (ed), Laboratory diagnosis of infectious diseases: principles and practice, vol 1. Springer-Verlag, New York, NY
55. Reed LJ, Muench H. 1938. A simple method of estimating fifty percent endpoints. Am J Hyg 27:493-497
56. Maslanka SE, Sharma S, Johnson EA. 2013. Clostridium botulinum and its toxins. In Tortorello ML, Doores S, Ito K, Salfinger Y (ed), Compendium of methods for the microbiological examination of foods. American Public Health Association, Washington, DC
57. Pellett S, Tepp WH, Toth SI, Johnson EA. 2010. Comparison of the primary rat spinal cord cell (RSC) assay and the mouse bioassay for botulinum neurotoxin type A potency determination. J Pharmacol Toxicol Methods 61:304-310. http://dx.doi.org/10.1016/j.vascn.2010.01.003